Polymyositis: the muscles that weaken from the middle out, the immune cause, and the treatment that pushes back
Last updated September 3, 2026.
Polymyositis is a rare autoimmune disease in which the immune system attacks the muscles, causing weakness that starts in the shoulders and hips and creeps up over weeks to months: getting out of a chair, climbing stairs, lifting arms overhead, and eventually swallowing and breathing muscles in severe cases. It is one of the inflammatory myopathies, the family that includes dermatomyositis, which adds a skin rash, and it is diagnosed from the story, blood tests for muscle enzymes, an EMG, an MRI, and often a muscle biopsy. Treatment is suppression of the immune attack, and it works in most people: high-dose steroids first, then a steroid-sparing medicine such as methotrexate, azathioprine, or mycophenolate for the long haul, with immune-globulin infusions and the newer biologics for those who need more. Recovery is real but slow and rarely a straight line: strength returns over months, the enzymes lead and the strength follows, and relapses happen, especially if treatment tapers too fast. The worth-knowing parts: physiotherapy is treatment, not an afterthought, because muscles rebuild strength faster while the inflammation is controlled; the steroids carry their own bill, bone thinning, weight gain, blood sugar, mood, and the team manages that bill actively; and dermatomyositis in particular, and polymyositis to a lesser degree, can be associated with an underlying cancer in older adults, so a new diagnosis in later life earns a cancer screen, which frightens people until it is reframed as thoroughness.
What does it look like?
Weakness, not pain at first: rising from a low chair, climbing stairs, lifting shopping, brushing hair, holding the arms up. It comes on over weeks to months, is symmetrical, both sides together, and is worst in the big muscles around the shoulders, hips, and neck. Later: fatigue, sometimes muscle aching, trouble swallowing, a weak voice, and shortness of breath if the breathing muscles or lungs are involved. In dermatomyositis, the rash arrives too: the violet eyelids and the rough red patches over the knuckles.
Why does it happen?
The immune system mistakes muscle tissue for a threat and sustains an attack on it, inflaming and breaking down the muscle fibers. Why it starts is unknown in most cases; it is commoner in women, in middle age, and sometimes alongside other autoimmune conditions. In older adults a new inflammatory myopathy can occasionally be the first sign of an underlying cancer, which is why a screen is part of the workup, not a cause for panic.
How is it treated?
- Steroids hit first and fast. High-dose prednisone switches off the worst of the attack; the dose then tapers slowly over months as the second-line medicine takes over.
- A steroid-sparing medicine carries the long term. Methotrexate, azathioprine, or mycophenolate keep the immune system suppressed at a fraction of the steroid bill, and immune-globulin infusions or biologics are the next line for tougher cases.
- Physiotherapy rebuilds what the disease took. Guided exercise while the inflammation is controlled restores strength faster and more safely than rest, and the swallowing and breathing muscles get their own therapists when needed.
- The screen and the monitoring run alongside. A cancer screen at diagnosis in older adults, regular strength and enzyme checks, bone protection while on steroids, and lung and heart checks, because the disease and its treatment both touch more than muscle.
When does it need urgent review?
New or worsening trouble swallowing, choking on fluids, a weak cough, or breathlessness earns same-day advice, because those are the signs the disease is reaching muscles that cannot wait. On steroids, a fever or new infection also earns prompt advice, because the immune system is being deliberately damped. Pymander's escalation routing is built and tested specifically for this class of decision; see the safety architecture working paper.
What a Pymander AI doctor consult looks like
Illustrative example, not a real member's messages.
Common questions
Will I get my strength back?
In most people with polymyositis, yes, substantially, and the sequence is worth knowing so the next months do not discourage you. The medicines switch off the immune attack first, and that shows in the blood: the muscle enzymes fall, usually within weeks, long before you feel stronger. The strength itself returns over months, because muscle that has been inflamed has to rebuild, and it rebuilds fastest with guided physiotherapy, which is treatment in this disease, not an optional extra. Expect an uneven curve, good weeks and flat weeks, and know that relapses happen to some people, usually when treatment tapers faster than the disease allows. The headline: most people get most of their strength and their ordinary lives back, and two weeks in is the hardest vantage point on the whole journey.
The steroids are making me wired, hungry, and round-faced. Does it last?
Those three are the classic steroid signatures, and they are dose-dependent, which is the good news: they shrink as the dose does, and the dose is planned to shrink. The high-dose phase is the heavy artillery, deliberately temporary, there to switch off the worst of the attack while the methotrexate, the long-haul manager, builds up. The taper runs over months, and the wired feeling, the ravenous appetite, and the face rounding all fade with it. The practical helps meanwhile: the team protects your bones while you are on steroids, the blood sugar and blood pressure get watched, and the mood effects are worth mentioning at appointments rather than enduring silently, because doses and timing can sometimes be adjusted. The bill is real and the team knows it; the taper is the exit and it is already the plan.
Is this my life now, one medicine after another?
For a while there is a medicines phase, and the honest frame is chapters, not a life sentence. Chapter one is the high-dose steroids, deliberately short because of their bill. Chapter two is the steroid-sparing medicine, methotrexate or one of its cousins, which carries the suppression at a fraction of the cost and on which many people settle for a few quiet years. Chapter three, which a good share of patients reach, is tapering down and sometimes off, because polymyositis sometimes burns out and stops needing suppression at all. The monitoring continues through all of it, the strength checks and the enzymes, so the medicines only ever run as long as the disease is asking for them. The goal of the whole apparatus is the opposite of a medicated life: it is to return you to the classroom and keep you there.
What is the methotrexate for, and is it safe to be on long term?
It is the long-haul manager: it suppresses the immune attack at a steady low level, which lets the steroids taper away, and that trade, a monitored weekly tablet instead of a daily high-dose steroid, is one of the best swaps in the autoimmune world. It has a track record measured in decades, and its safety rests on the monitoring you will barely notice after a while: regular blood tests for the liver and the blood counts, which catch the rare problems early. The practical rules worth knowing: it is once a week, not daily, and mixing that up is the dangerous error; the folic acid alongside it softens the side effects; alcohol becomes a rare and modest thing; and it must be stopped well before any pregnancy, which your team will raise if it applies. Most people tolerate it quietly, and quietly is the point.
Should I be exercising or resting while I am weak?
Exercising, guided and graduated, because in this disease physiotherapy is treatment, not an afterthought. The old instinct was to rest inflamed muscle, and the evidence has flipped: once the inflammation is being controlled by the medicines, progressive exercise rebuilds strength faster and more safely than rest, and resting through the recovery phase leaves people weaker than they need to be. The emphasis is on guided: a physiotherapist who knows myositis sets the starting point and the increments, because doing too much on a good day and paying for it for three is the classic self-managed mistake. The swallowing and breathing muscles get their own specialists if they are affected. And the marker moment is worth anticipating: the first time you rise from a chair without planning it, write it down, because that is the disease retreating.
Why did the team mention cancer screening at my age? Should I be frightened?
The mention is thoroughness, not suspicion, and it is worth reframing before it frightens you. Inflammatory myopathies that appear in later adulthood are occasionally, in a minority of cases, the immune system's reaction to an underlying cancer rather than a disease of the muscles alone, and dermatomyositis carries this association more strongly than polymyositis. Because of that link, the guidelines say a new diagnosis in an older adult earns an up-to-date cancer screen, the age-appropriate checks plus whatever your story suggests. The large majority of screens find nothing, and the finding of nothing closes the question. Think of it as the team being the kind of thorough you would want them to be, and file it alongside the bone protection and the lung checks: this disease touches more than muscle, and so does good care of it.